Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

SERNOVA CORP V.SVA

Sector: Healthcare | Sub-Sector: Diagnostics & Research
Alternate Symbol(s):  SEOVF

Sernova Corp is a clinical stage biotechnology company. It is engaged in the research and development of a commercially-viable treatment for insulin-dependent human diabetes and other metabolic, blood and neurological diseases.
Price: $0.22 | Change: $-0.01 | %Change: -4.35%
Volume: 10,443 | Day High/Low: 0.22/0.22 | 52 Week High/Low: 0.34/0.10

Snapshot

Last Traded: August 21, 2014 09:39 Transaction Volume: 10,443
Open: $0.22 Previous Close: $0.23
Bid: $0.22 Ask: $0.23
Bid Size: 37,500 Ask Size: 33,000
Market Cap: $28.6m Shares Out: 129.8m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Opinion

Sernova (V.SVA) puts focus on diabetes treatment device

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   May 16, 2014
0 stars

Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Progress update on Sernova and N.A. Nickel

Sernova’s product focus is on treating insulin-dependent diabetes. NAN is focused on greenfields nickel exploration.

Richard (Rick) Mills   July 17, 2012
0 stars

Latest Bullboard Posts

  • RE:RE:RE:SVA SP is Sick

    0 stars

    I would not disagree in any way with your comment about the role of PR.  The investor reaction to having a proven system will undoubtedly...

    2 stars


  • RE:RE:SVA SP is Sick

    5 stars

    Donkeyfeathers,  You have your arms completely around this opportunity.  Your posts are very impressive and always grounded in reality...

    2.5 stars


  • RE:SVA SP is Sick

    4 stars

    Here's the Reader's Digest version of a post from Oct.1/2013... Not that I want to dismantle the dreams of those who see the potential...

    2 stars


  • SVA SP is Sick

    5 stars

    What a completely terrible investment this has been......given all of the horsepower surrounding this thing you would think there would...

    2.5 stars


  • finacing

    0 stars

    Of course there will be future finacings. To get through primary will require a lot of money. There should be a strategic partner by then...

    1 star